Carter, B., Mak, P. Y., Ostermann, L., Ordentlich, P., Andreeff, M. (2025). CSF1R-CSF1 axis blockade with axatilimab effectively targets leukemia stem cells and monocytes in AML resistant to BH3 mimetics. Blood. https://doi.org/10.1182/blood-2025-3276